← FDA Drug Approvals (Drugs@FDA)

APRESAZIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVARTIS · Approved 1976-05-26

Drug application

FDA Application #

ANDA084811

Application type

Abbreviated New Drug Application (Generic)

Brand name

APRESAZIDE

Generic name

Hydralazine Hydrochloride

Active ingredients

HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

1976-05-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown